Margaret Anderson Headshot
Report a problem with this profile
[email protected]

Margaret Anderson      

Managing Director of Deloitte Consulting

Margaret Anderson is a Managing Director with Deloitte Consulting. She’s focused on bringing her experience in research innovation and patient engagement to strengthen nonprofits, as well as federal and commercial life sciences programs.

She joined Deloitte from FasterCures, a center of the Milken Institute where she was Executive Director. She also worked at the American Public Health Association on HIV/AIDS issues, and at the Congressional Office of Technology Assessment studying genetics and society.

Anderson is a past-president of the Alliance for a Stronger FDA, and was a member of the NIH National Center for Advancing Translational Sciences Advisory Council and the Cures Acceleration Network Review Board. She currently serves on the Board of Act for NIH, the Asthma and Allergy Foundation of America, FasterCures, Friends of Cancer Research, and the Melanoma Research Alliance. Anderson has a Bachelor’s from University of Maryland in Government and Politics and a Master’s from George Washington in Science, Technology and Public Policy.


FasterCures to Further Accelerate Biomedical Innovation with $3 Million Grant from Helmsley Charitable Trust
NEW YORK, March 14, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has awarded FasterCures, a center of the Milken Institute, a three-year, $3 million grant to support its quest to improve medical research systems and accelerate the pace at which patients gain access to life-saving treatments and therapies. Specifically, the funding will support two of FasterCures' key programs, Patients Count: The Science of Patient Input and Collaboration 2.0 ...
Top Ten Medical Research Issues and Trends to Watch in 2017
2016 will go down as a year that taught us to question our assumptions. The election of Donald Trump, an outcome almost no one predicted, left many with a sense of uncertainty about what 2017 will bring in the biomedical and health-care space. To bring clarity to these unsure times, FasterCures has compiled a list of issues critical to the future of medical innovation that we’ll be tracking over the coming year. While some issues will be closely linked with the people and policies of the new presidential administration, we think all will be important to continuing the progress toward faster cures and treatments ...

Related Speakers View all

More like Margaret